EARLI
Live / Applied — Second extension granted (statement of use) (as of 25 Oct 2025)
What this means for you
Not registered yet, but its 27 Jan 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97770271
- Mark type
- Stylized text
- Filed
- 27 Jan 2023
- Published for opposition
- 15 Oct 2024
- Attorney of record
- Connie Ellerbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations and products for medical purposes for the prevention, detection, localization, and treatment of infectious viral-based, diseases, infectious bacterial-based diseases, infectious fungal-based diseases, autoimmune diseases, allergies, heart- and vascular-based diseases, cerebrovascular disease, neurological disorders and diseases, metabolic diseases, genetic diseases, blood-based diseases, kidney diseases, pancreatic diseases, muscular and neuromuscular diseases, gastrointestinal diseases and conditions, and toxins in the body tissue and fluids of humans and animals; Drug delivery agents in the form of tablet coatings, edible wafers, powders, tablets, and capsules that facilitate the delivery of other pharmaceutical preparations into human and animal bodies; Reagents for use in therapeutics for medical purposes; Diagnostic and therapeutic preparations for medical purposes, namely, diagnostic preparations and therapeutic pharmaceutical preparations for detecting and treating infectious viral-based diseases, infectious bacterial-based diseases, infectious fungal based diseases, autoimmune diseases, allergies, heart- and vascular-based diseases, cerebrovascular disease, neurological disorders and diseases, metabolic diseases, genetic diseases, blood-based diseases, kidney diseases, pancreatic diseases, muscular and neuromuscular diseases, and gastrointestinal diseases and conditions, and for detecting the presence of toxins in body tissue and fluids; medical diagnostic reagents and assays for testing of body fluids, reagents for medical use, diagnostic reagents for medical uses, enzymes for medical purposes, and diagnostic nucleotides for medical use; medical diagnostic assays for testing of body fluids, biological preparations in the nature of recombinant nucleic acid vectors, biological preparations in the nature of recombinant viral vectors, transfection agents being reagents for medical use, reagents for medical use, enzymes for medical purposes, and diagnostic nucleotides for medical purposes, and diagnostic nucleotides for medical use, all for the foregoing being for the treatment of infectious viral-based, diseases, infectious bacterial-based diseases, infectious fungal-based diseases, autoimmune diseases, allergies, heart- and vascular-based diseases, cerebrovascular disease, neurological disorders and diseases, metabolic diseases, genetic diseases, blood-based diseases, kidney diseases, pancreatic diseases, muscular and neuromuscular diseases, gastrointestinal diseases and conditions, and toxins in the body tissue and fluids of humans and animals; medical diagnostic assays and reagents for testing of body fluids, reagents for medical use, enzymes for medical purposes, and diagnostic nucleotides for medical use, all the forgoing for medical diagnostic and treatment purposes, namely, for use in detecting and treating infectious viral-based diseases, infectious bacterial-based diseases, infectious fungal-based diseases, autoimmune diseases, allergies, heart- and vascular-based diseases, cerebrovascular disease, neurological disorders and diseases, metabolic diseases, genetic diseases, blood-based diseases, kidney diseases, pancreatic diseases, muscular and neuromuscular diseases, and gastrointestinal diseases and conditions, and for use in detecting the presence of toxins in body tissue and fluids and for eliminating toxins from body tissue and fluids; therapeutic diagnostic agents for medical purposes, therapeutic agents in the nature of therapeutic pharmaceuticals for the treatment of cancer, infectious viral-based diseases, infectious bacterial-based diseases, infectious fungal-based diseases, autoimmune diseases, allergies, respiratory diseases, heart- and vascular-based diseases, cerebrovascular disease, neurological disorders and diseases, metabolic diseases, genetic diseases, blood-based diseases, kidney diseases, liver and pancreatic diseases, muscular and neuromuscular diseases, and gastrointestinal diseases and conditions, and therapeutic agents being therapeutic diagnostic and pharmaceutical preparations for detecting the presence of toxins in body tissue and fluid and for eliminating toxins from body tissue and fluids; therapeutic agents for medical diagnostic purposes and treatment purposes, namely, biological preparation in the nature of viral vectors and non-viral transfection agents being reagents for medical use based on linear or branched polyethyleneimines, nano-particles, lipophilic particles, peptides, micelles, dendrimers, hydrogels, synthetic or naturally derived exosomes, polymeric composition, or virus-like particles, that facilitate the delivery of a wide range of pharmaceuticals or nucleic acid sequences into human and animal bodies to detect and treat infectious viral-based diseases, infectious bacterial-based diseases, infectious fungal-based diseases, autoimmune diseases, allergies, heart- and vascular-based diseases, cerebrovascular disease, neurological disorders and diseases, metabolic diseases, genetic diseases, blood-based diseases, kidney diseases, pancreatic diseases, muscular and neuromuscular diseases, and gastrointestinal diseases and conditions, and for eliminating toxins in body tissue and fluids
- Class 009 — Scientific and electric apparatus: Scientific apparatus in the nature of medical laboratory research instruments for the detection and localization of diseases, pathogens and toxins in a biological sample obtained from humans and animals for research use
- Class 010 — Medical apparatus: Medical devices for delivering pharmaceutical preparations and genetic material into human or animal tissues and cells for the purpose of diagnosis of disease or treatment of disease, pathogens, and toxins in humans and animals, namely, syringes, implantable drug delivery pumps with and without catheters, infusion pumps, drug delivery catheters, infusion sets, cannulas, transdermal drug delivery patches, autoinjectors being injection devices for administering drugs, electroporators being electromagnetic drug delivery apparatus for medical use, and inhaled delivery devices being inhalers for medical purposes, all the forgoing sold empty and without medication; Medical devices for the delivery of pharmaceutical preparations and genetic material into human or animal tissues and cells for the purpose of diagnosis of disease or treatment of disease, pathogens, and toxins in humans and animals, namely, inhalers for medical purposes, sold empty and drug delivery patches sold without medication; Medical instruments for use in treating infectious diseases and for eliminating pathogens and toxins in humans and animals
Owner
Prosecution history
- 26 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Oct 2025 — SOU EXTENSION 2 GRANTED
- 25 Oct 2025 — SOU EXTENSION 2 FILED
- 25 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Mar 2025 — SOU EXTENSION 1 GRANTED
- 06 Mar 2025 — SOU EXTENSION 1 FILED
- 06 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Oct 2024 — PUBLISHED FOR OPPOSITION
- 25 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Aug 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Aug 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE